Phase I clinical trial of TBI 304H for the treatment of chemotherapy-induced anaemia.

Trial Profile

Phase I clinical trial of TBI 304H for the treatment of chemotherapy-induced anaemia.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Apr 2015

At a glance

  • Drugs TBI 304 (Primary)
  • Indications Chemotherapy-induced anaemia
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors Therapure Biopharma
  • Most Recent Events

    • 09 Apr 2015 Status changed from not yet recruiting to recruiting, as reported in an Abzena media release.
    • 17 Mar 2015 New trial record
    • 11 Mar 2015 US FDA grants approval for the trial to proceed, according to a Therapure Innovations media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top